1. Home
  2. EVOK vs SINT Comparison

EVOK vs SINT Comparison

Compare EVOK & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • SINT
  • Stock Information
  • Founded
  • EVOK 2007
  • SINT 1996
  • Country
  • EVOK United States
  • SINT United States
  • Employees
  • EVOK N/A
  • SINT N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • SINT Medical/Dental Instruments
  • Sector
  • EVOK Health Care
  • SINT Health Care
  • Exchange
  • EVOK Nasdaq
  • SINT Nasdaq
  • Market Cap
  • EVOK 7.7M
  • SINT 7.9M
  • IPO Year
  • EVOK 2013
  • SINT 2014
  • Fundamental
  • Price
  • EVOK $4.43
  • SINT $2.80
  • Analyst Decision
  • EVOK
  • SINT Strong Buy
  • Analyst Count
  • EVOK 0
  • SINT 1
  • Target Price
  • EVOK N/A
  • SINT $28.00
  • AVG Volume (30 Days)
  • EVOK 7.2M
  • SINT 231.7K
  • Earning Date
  • EVOK 08-12-2025
  • SINT 08-12-2025
  • Dividend Yield
  • EVOK N/A
  • SINT N/A
  • EPS Growth
  • EVOK N/A
  • SINT N/A
  • EPS
  • EVOK N/A
  • SINT N/A
  • Revenue
  • EVOK $11,594,083.00
  • SINT $2,569,000.00
  • Revenue This Year
  • EVOK $57.82
  • SINT N/A
  • Revenue Next Year
  • EVOK $59.12
  • SINT $87.50
  • P/E Ratio
  • EVOK N/A
  • SINT N/A
  • Revenue Growth
  • EVOK 89.89
  • SINT N/A
  • 52 Week Low
  • EVOK $1.94
  • SINT $1.71
  • 52 Week High
  • EVOK $12.32
  • SINT $8.60
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 53.72
  • SINT 42.97
  • Support Level
  • EVOK $4.26
  • SINT $2.52
  • Resistance Level
  • EVOK $4.73
  • SINT $2.94
  • Average True Range (ATR)
  • EVOK 0.73
  • SINT 0.19
  • MACD
  • EVOK -0.07
  • SINT -0.05
  • Stochastic Oscillator
  • EVOK 25.95
  • SINT 29.09

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: